Mollie Leoni serves as Executive at Kura Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Mollie Leoni has executed 6 insider transactions totaling $283.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 100,000 shares valued at $0.
Mollie Leoni currently holds 100,000 shares of Kura Oncology, Inc. (KURA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mollie Leoni has been a net seller of KURA stock. They have purchased $0 and sold $283.2K worth of shares.
Mollie Leoni's most recent insider trade was on Jan 2, 2026, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 14, 2025 | KURA | $173.1K | Sale | 15,485 | $11.18 | Discretionary |
| Nov 13, 2025 | KURA | $0 | Award | 82,500 | $N/A | Discretionary |
| Sep 29, 2025 | KURA | $110.1K | Sale | 12,314 | $8.94 | Discretionary |
| Sep 27, 2025 | KURA | $0 | Award | 82,500 | $N/A | Discretionary |